1800009I advanced bioscience laboratories, INC.; to V4 pipb--1 base task order funding; IID can 8470036 $173,773
Active Awarded Last action
- Contract number
- 75N93019F00131
- Awardee
-
Advanced Bioscience Laboratories, Inc. UEI MK4QC9EKZXG8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $534,190
Award facts
- Opportunity
-
- RFPDMIDNIAIDNIHAI2017089 Solicitation number
- Contract value 100% obligated
- $534,190.43 Current and potential, with all options
- Completion date 83% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$14,787 | |
| Funding Only Action | $208,053 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $167,151 | |
| Original award | $173,773 |
About this award
This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Advanced Bioscience Laboratories, Inc. (ABL), a for-profit manufacturer of goods. The $173,773 award is for a base task order under a larger Indefinite Delivery Vehicle (IDV) valued at $534,190.43. The contract is for the manufacture and characterization of vaccines, with a period of performance ending on May 14, 2028. The contract is cost-plus-fixed-fee and does not have a set-aside designation. ABL is a leading contract research and manufacturing organization specializing in the development of gene therapies, vaccines, oncolytics, and immunotherapies. The company has supported various programs for NIAID, the National Cancer Institute (NCI), and the National Institute of Neurological Disorders and Stroke (NINDS), including the development of vaccines and therapeutics for infectious diseases and cancer.
Quick answers
Who was awarded contract 75N93019F00131?
75N93019F00131 was awarded to Advanced Bioscience Laboratories, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on April 15, 2019.
How much is contract 75N93019F00131 worth?
The government has obligated $534,190 on 75N93019F00131.
Is contract 75N93019F00131 an order under another contract?
Yes. 75N93019F00131 is a delivery order under 75N93018D00009, an indefinite delivery contract.
Was contract 75N93019F00131 competed?
The extent of competition for 75N93019F00131 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award